Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PRLD | Prelude Therapeutics Inc | CEO, Director | $1.87M | +$699K | +59.9% | Mar 25, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|